Protalix BioTherapeutics (PLX) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PLX Stock Alerts $1.15 -0.03 (-2.54%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Protalix BioTherapeutics Stock Price Performance5 Day Performance-2.54%1 Month Performance-7.63%3 Month Performance-22.30%6 Month Performance-20.42%Year-To-Date Performance-35.39%1 Year Performance-53.44% Receive PLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. PLX Stock Chart for Saturday, April, 27, 2024 PLX Chart by TradingView Protalix BioTherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.18$1.15-2.54%$1.22$1.09958,735 shs$84.01 million04/25/2024$1.21$1.18-2.48%$1.22$1.16192,145 shs$86.20 million04/24/2024$1.20$1.21+0.83%$1.23$1.17227,105 shs$88.39 million04/23/2024$1.18$1.20+1.69%$1.24$1.17272,095 shs$87.66 million04/22/2024$1.15$1.18+2.61%$1.18$1.12225,065 shs$86.20 million04/19/2024$1.13$1.15+1.77%$1.17$1.10449,784 shs$84.01 million Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$1.15$1.13-1.74%$1.17$1.09421,188 shs$82.55 million04/17/2024$1.16$1.15-0.43%$1.20$1.14366,058 shs$84.01 million04/16/2024$1.15$1.16+0.43%$1.17$1.13291,488 shs$84.37 million04/15/2024$1.18$1.15-2.54%$1.21$1.14429,127 shs$84.01 million04/12/2024$1.22$1.18-3.28%$1.24$1.18341,088 shs$86.20 million04/11/2024$1.27$1.22-3.94%$1.28$1.20287,765 shs$89.12 million04/10/2024$1.32$1.27-3.79%$1.33$1.25316,225 shs$92.77 million04/09/2024$1.31$1.32+1.15%$1.35$1.29220,438 shs$96.43 million04/08/2024$1.17$1.31+11.54%$1.33$1.18905,577 shs$95.33 million04/05/2024$1.22$1.18-3.29%$1.23$1.17426,500 shs$85.83 million04/04/2024$1.24$1.22-2.02%$1.26$1.21240,638 shs$88.76 million04/03/2024$1.24$1.24$1.26$1.23276,412 shs$90.58 million04/02/2024$1.25$1.24-0.80%$1.28$1.23253,655 shs$90.58 million04/01/2024$1.26$1.25-0.79%$1.28$1.25278,550 shs$91.31 million03/29/2024$1.26$1.26$1.28$1.24282,403 shs$92.04 million03/28/2024$1.25$1.26+1.20%$1.28$1.24281,402 shs$92.05 million03/27/2024$1.22$1.25+2.05%$1.28$1.22378,688 shs$90.95 million03/26/2024$1.25$1.22-2.01%$1.25$1.22355,581 shs$89.12 million03/25/2024$1.27$1.25-1.97%$1.31$1.21707,391 shs$90.95 million03/22/2024$1.32$1.27-3.79%$1.32$1.26249,037 shs$92.77 million03/21/2024$1.34$1.32-1.49%$1.37$1.30294,414 shs$96.43 million03/20/2024$1.30$1.34+3.08%$1.35$1.27328,866 shs$97.89 million03/19/2024$1.29$1.30+0.78%$1.32$1.26405,416 shs$94.97 million03/18/2024$1.33$1.29-3.01%$1.33$1.27696,690 shs$92.34 million03/15/2024$1.37$1.33-2.92%$1.40$1.32577,845 shs$95.20 million03/14/2024$1.50$1.37-8.67%$1.54$1.361.25 million shs$98.07 million03/13/2024$1.43$1.50+4.90%$1.54$1.43457,794 shs$107.37 million03/12/2024$1.45$1.43-1.04%$1.50$1.43371,923 shs$102.36 million03/11/2024$1.49$1.45-3.02%$1.51$1.45221,800 shs$103.43 million03/08/2024$1.46$1.50+2.40%$1.52$1.47227,179 shs$107.01 million03/07/2024$1.49$1.46-2.01%$1.50$1.46273,114 shs$104.51 million03/06/2024$1.52$1.49-1.97%$1.54$1.49501,037 shs$106.65 million03/05/2024$1.57$1.52-3.18%$1.56$1.51211,360 shs$108.80 million03/04/2024$1.62$1.57-3.09%$1.64$1.55267,002 shs$112.38 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$1.63$1.62-0.61%$1.67$1.61477,768 shs$115.96 million02/29/2024$1.54$1.63+5.84%$1.66$1.57566,213 shs$116.68 million02/28/2024$1.56$1.54-1.28%$1.58$1.54194,021 shs$110.23 million02/27/2024$1.49$1.56+4.70%$1.58$1.50421,492 shs$111.67 million02/26/2024$1.45$1.49+2.76%$1.54$1.45418,498 shs$106.65 million02/23/2024$1.44$1.46+1.74%$1.49$1.43270,386 shs$104.51 million02/22/2024$1.42$1.44+1.06%$1.47$1.43257,985 shs$102.72 million02/21/2024$1.44$1.42-1.39%$1.47$1.41297,927 shs$101.64 million02/20/2024$1.47$1.44-2.04%$1.49$1.43386,740 shs$103.08 million02/19/2024$1.47$1.47$1.53$1.47284,300 shs$105.22 million02/16/2024$1.52$1.48-2.63%$1.53$1.47284,213 shs$105.94 million02/15/2024$1.48$1.52+2.70%$1.53$1.48344,912 shs$108.80 million02/14/2024$1.43$1.48+3.50%$1.51$1.41270,943 shs$105.94 million02/13/2024$1.50$1.43-4.35%$1.49$1.42342,063 shs$102.36 million02/12/2024$1.47$1.50+1.70%$1.54$1.48310,280 shs$107.01 million02/09/2024$1.50$1.47-2.00%$1.51$1.45236,002 shs$105.22 million02/08/2024$1.48$1.50+1.35%$1.51$1.45208,659 shs$107.37 million02/07/2024$1.53$1.48-2.95%$1.53$1.47202,029 shs$105.94 million02/06/2024$1.44$1.53+5.90%$1.53$1.45224,887 shs$109.16 million02/05/2024$1.45$1.44-0.69%$1.47$1.43228,426 shs$103.08 million02/02/2024$1.48$1.45-1.69%$1.49$1.43248,109 shs$103.79 million02/01/2024$1.45$1.48+1.72%$1.50$1.43288,874 shs$105.58 million01/31/2024$1.50$1.45-3.01%$1.52$1.45311,251 shs$103.79 million01/30/2024$1.53$1.50-2.29%$1.55$1.49147,642 shs$107.01 million01/29/2024$1.48$1.53+3.38%$1.54$1.47232,094 shs$109.52 million01/26/2024$1.51$1.49-1.33%$1.55$1.48264,838 shs$106.30 million Related Companies: Atara Biotherapeutics Stock Price Chart CEL-SCI Stock Price Chart AlloVir Stock Price Chart Sangamo Therapeutics Stock Price Chart Cognition Therapeutics Stock Price Chart Elutia Stock Price Chart Curis Stock Price Chart Instil Bio Stock Price Chart Cidara Therapeutics Stock Price Chart Entera Bio Stock Price Chart Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PLX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.